GO:0004736 pyruvate carboxylase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004736 pyruvate carboxylase activity catalyzes the ATP-dependent carboxylation of pyruvate to oxaloacetate, a critical anaplerotic reaction replenishing the TCA cycle.
• The enzyme is a biotin-dependent carboxylase that requires acetyl-CoA as an allosteric activator and is regulated by its structural dynamics.
• Pyruvate carboxylase (PC) is essential in gluconeogenic tissues, lipogenesis, neurotransmitter synthesis, and insulin secretion.
• Dysregulation of PC is implicated in cancers, renal fibrosis, atherosclerosis, and metabolic reprogramming of immune cells [1,2,5,8].
• Key genes include PC (pyruvate carboxylase), PCK1, PCK2, and metabolic regulators such as HIF1A and SQOR that interact with PC pathways [2,5].
• CRISPR knockout, point mutation, knock-in, and overexpression models enable precise dissection of PC function in health and disease [1,2,5].
Description
Pyruvate carboxylase activity (GO:0004736) is a fundamental anaplerotic reaction that converts pyruvate to oxaloacetate using ATP and bicarbonate, thereby replenishing tricarboxylic acid (TCA) cycle intermediates and supporting gluconeogenesis, lipogenesis, and neurotransmitter biosynthesis. This enzyme is a member of the biotin-dependent carboxylase family and is highly conserved across species, with its activity tightly regulated by acetyl-CoA and structural transitions. In biomedical research, pyruvate carboxylase (PC) has emerged as a key node in metabolic reprogramming, with roles in cancer metabolism, immune cell function, and organ fibrosis [1,2,5,8]. Understanding its mechanism, regulation, and disease connections is essential for developing targeted therapies and metabolic interventions.
pyruvate carboxylase activity At A Glance
| GO ID | GO:0004736 |
|---|---|
| GO term | pyruvate carboxylase activity |
| Ontology | molecular_function |
| Synonym | pyruvate:carbon-dioxide ligase (ADP-forming); pyruvic carboxylase activity |
| Major function | ATP-dependent carboxylation of pyruvate to oxaloacetate, an anaplerotic reaction replenishing TCA cycle intermediates |
| Cofactor | Biotin, covalently attached to the enzyme; requires acetyl-CoA as allosteric activator |
| Reaction | ATP + bicarbonate + pyruvate = ADP + 2 H+ + oxaloacetate + phosphate |
| EC number | 6.4.1.1 |
| Localization | Mitochondrial matrix in eukaryotes |
What Is GO:0004736?
Pyruvate carboxylase activity (GO:0004736) is defined as the catalysis of the reaction: ATP + bicarbonate + pyruvate = ADP + 2 H+ + oxaloacetate + phosphate. This reaction requires biotin as a cofactor and proceeds through a two-step mechanism involving carboxylation of biotin and subsequent transfer of the carboxyl group to pyruvate [3,7].
Why Is pyruvate carboxylase activity Important in Cell Biology?
Pyruvate carboxylase activity is indispensable for maintaining metabolic homeostasis. It provides oxaloacetate for the TCA cycle, supports gluconeogenesis from lactate and amino acids, and supplies citrate for lipogenesis [3,7]. Its dysregulation is linked to cancer progression, renal fibrosis, atherosclerosis, and immune cell dysfunction, making it a promising therapeutic target [1,2,5,8].
• Critical for gluconeogenesis in liver and kidney, maintaining blood glucose during fasting.
• Supplies oxaloacetate for TCA cycle anaplerosis, supporting energy production and biosynthesis.
• Required for de novo lipogenesis by providing citrate for fatty acid synthesis.
• Essential for neurotransmitter synthesis (e.g., glutamate, GABA) in the brain.
• Plays a role in insulin secretion by pancreatic beta cells.
• Implicated in cancer metabolism, where PC supports tumor growth and survival.
• Deletion in renal tubular cells promotes fibrosis via SQOR/cGAS/STING-mediated glycolysis.
• In macrophages, PC aggravates atherosclerosis by promoting inflammatory responses through HIF-1 signaling.
• Modulates anti-tumor immune responses by altering pyruvate utilization in CD8+ T cells.
• Targeted by small-molecule activators such as ganoderic acid T for anti-liver cancer activity.
Molecular Mechanism of pyruvate carboxylase activity
Substrate Binding and Activation
In simple terms: The enzyme first binds its substrates and an activator to get ready for the reaction.
Pyruvate carboxylase (PC) binds pyruvate, ATP, and bicarbonate in its active site. Acetyl-CoA acts as an essential allosteric activator, inducing conformational changes that facilitate catalysis. The enzyme exists as a tetramer and undergoes significant structural rearrangements upon acetyl-CoA binding, which enhances substrate affinity and catalytic efficiency [4,7].
Biotin Carboxylation
In simple terms: A biotin molecule attached to the enzyme gets a carboxyl group added to it.
The first half-reaction involves the carboxylation of the biotin prosthetic group using bicarbonate and ATP. The biotin carboxylase domain catalyzes the formation of carboxybiotin, with ATP hydrolysis providing the energy [3,7]. This step requires Mg2+ as a cofactor and proceeds via a carboxyphosphate intermediate.
Carboxyl Transfer to Pyruvate
In simple terms: The carboxyl group is moved from biotin onto pyruvate to make oxaloacetate.
In the second half-reaction, the carboxyl group is transferred from carboxybiotin to pyruvate, yielding oxaloacetate and free biotin. This step occurs in the carboxyltransferase domain and involves a large conformational change that translocates the biotin between active sites [3,7]. The reaction is essentially irreversible under physiological conditions.
Allosteric Regulation by Acetyl-CoA
In simple terms: Acetyl-CoA acts like a switch that turns the enzyme on when energy is abundant.
Acetyl-CoA is a positive allosteric effector that binds to the enzyme and promotes the formation of the active tetrameric state. It lowers the Km for bicarbonate and increases Vmax, coupling PC activity to the energy status of the cell. This regulation ensures that oxaloacetate production is stimulated when acetyl-CoA is plentiful, such as during fatty acid synthesis.
Structural Dynamics and Catalytic Cycle
In simple terms: The enzyme changes shape dramatically during its catalytic cycle to move molecules between different sites.
PC is a multidomain enzyme comprising biotin carboxylase (BC), carboxyltransferase (CT), and biotin carboxyl carrier protein (BCCP) domains. The BCCP domain swings between BC and CT domains to shuttle carboxybiotin, a process driven by domain rotations. Crystal structures have revealed that acetyl-CoA binding induces a 45-degree rotation of the BC domain, enabling efficient catalysis [4,7].
Key Genes Involved in GO:0004736 pyruvate carboxylase activity
The following genes and proteins are directly involved in or closely associated with pyruvate carboxylase activity and its regulatory network.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PC | Encodes pyruvate carboxylase, the enzyme catalyzing the reaction | Central to anaplerosis, gluconeogenesis, and metabolic diseases [3,7] |
| PCK1 | Phosphoenolpyruvate carboxykinase 1, converts oxaloacetate to PEP | Works downstream of PC in gluconeogenesis |
| PCK2 | Mitochondrial PEPCK, supports gluconeogenesis and glyceroneogenesis | Interacts with PC in metabolic pathways |
| ACACA | Acetyl-CoA carboxylase alpha, produces malonyl-CoA for lipogenesis | Acetyl-CoA is a shared activator and substrate |
| HIF1A | Hypoxia-inducible factor 1-alpha, regulates glycolysis and inflammation | Mediates PC-driven inflammatory responses in macrophages |
| SQOR | Sulfide:quinone oxidoreductase, regulates glycolysis and oxidative stress | PC deletion alters SQOR/cGAS/STING signaling in renal fibrosis |
| CGAS | Cyclic GMP-AMP synthase, sensor of cytosolic DNA | Involved in PC deletion-induced fibrosis via STING |
| STING1 | Stimulator of interferon response cGAMP interactor 1 | Mediates inflammatory signaling downstream of PC loss |
| SLC2A1 | GLUT1 glucose transporter, facilitates glucose uptake | Glycolysis regulation linked to PC status |
| LDHA | Lactate dehydrogenase A, converts pyruvate to lactate | Competes with PC for pyruvate; altered in PC-deficient cells |
| PDHA1 | Pyruvate dehydrogenase E1 alpha, converts pyruvate to acetyl-CoA | Balances pyruvate flux between oxidation and carboxylation |
| CS | Citrate synthase, condenses oxaloacetate and acetyl-CoA | Uses PC-derived oxaloacetate for citrate production |
| G6PC | Glucose-6-phosphatase, final step of gluconeogenesis | Downstream of PC in glucose production |
| FASN | Fatty acid synthase, de novo lipogenesis | Requires PC-derived citrate for fatty acid synthesis |
| SLC25A1 | Mitochondrial citrate carrier | Exports citrate for lipogenesis, linked to PC activity |
| MDH2 | Malate dehydrogenase 2, TCA cycle enzyme | Converts PC-derived oxaloacetate to malate |
| GOT2 | Glutamate oxaloacetate transaminase 2 | Uses oxaloacetate for aspartate synthesis |
| PCK1 | Phosphoenolpyruvate carboxykinase 1 | Key gluconeogenic enzyme downstream of PC |
How Is pyruvate carboxylase activity Regulated?
Pyruvate carboxylase activity is regulated at multiple levels. Allosterically, acetyl-CoA is a potent activator that induces conformational changes and promotes tetramerization, while ADP and other metabolites can modulate activity. Transcriptional regulation of PC is influenced by metabolic hormones such as glucagon and insulin, and by transcription factors like FOXO1 and CREB. Post-translational modifications, including acetylation and phosphorylation, may also affect PC activity, though these are less well characterized. In disease contexts, PC expression is regulated by hypoxia-inducible factors (HIFs) and oncogenic signaling pathways.
pyruvate carboxylase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PC | Liver cancer, metabolic reprogramming | PC overexpression or knockout in hepatoma cell lines |
| PC | Renal fibrosis | Tubular epithelial cell-specific PC knockout mice |
| PC | Atherosclerosis | Macrophage-specific PC knockout or overexpression in ApoE-/- mice |
| PC | Gluconeogenic disorders | Liver-specific PC knockout mice |
| PC | Anti-tumor immunity | CD8+ T cell-specific PC knockout in tumor models |
Cancer Metabolism
Pyruvate carboxylase supports tumor growth by replenishing TCA cycle intermediates and providing precursors for biosynthesis. In liver cancer, activation of PC by ganoderic acid T exhibits potent anti-tumor activity, suggesting that PC modulation can be therapeutically exploited. Tumor cells can also dictate anti-tumor immune responses by altering pyruvate utilization in CD8+ T cells, where PC plays a role in succinate signaling.
Renal Fibrosis
Deletion of pyruvate carboxylase in tubular epithelial cells promotes renal fibrosis by regulating SQOR/cGAS/STING-mediated glycolysis. Loss of PC leads to metabolic reprogramming and activation of inflammatory pathways, highlighting its protective role in kidney homeostasis.
Atherosclerosis
In macrophages, pyruvate carboxylase aggravates atherosclerosis by regulating metabolic reprogramming to promote inflammatory responses through the hypoxia-inducible factor-1 signaling pathway. This suggests that PC inhibition could be a strategy to reduce atherosclerotic inflammation.
Metabolic Disorders
PC deficiency in humans causes lactic acidosis and neurological impairment, underscoring its essential role in gluconeogenesis and neurotransmitter synthesis. Additionally, PC activity is critical for hepatic glucose production, and its dysregulation contributes to hyperglycemia in diabetes.
From pyruvate carboxylase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of PC loss on tumor growth? | PC knockout in cancer cell lines (e.g., CRISPR-Cas9) |
| How does PC deletion in renal tubules affect fibrosis? | Tubular epithelial cell-specific PC knockout mice |
| Does PC in macrophages promote atherosclerosis? | Macrophage-specific PC knockout in ApoE-/- mice |
| Can PC activation inhibit liver cancer? | PC overexpression or small-molecule activator treatment |
| How does PC regulate CD8+ T cell function? | PC knockout in primary CD8+ T cells followed by adoptive transfer |
| What is the role of PC in hepatic gluconeogenesis? | Liver-specific PC knockout or knockdown |
How to Study the pyruvate carboxylase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Spectrophotometric assay | PC enzymatic activity via NADH oxidation | In vitro enzyme kinetics and inhibitor screening |
| Hyperpolarized 13C MRS | Real-time PC flux in vivo | Non-invasive assessment of hepatic PC activity |
| 13C metabolic flux analysis | Flux of pyruvate to oxaloacetate and downstream metabolites | Cancer and immune cell metabolism studies |
| CRISPR-Cas9 knockout | Loss-of-function phenotypes | Studying PC roles in disease models [2,5] |
| Western blot | PC protein expression levels | Validation of genetic manipulation |
| Immunofluorescence | Subcellular localization of PC | Mitochondrial targeting studies |
| qRT-PCR | PC mRNA expression | Transcriptional regulation analysis |
| Seahorse XF analyzer | Glycolysis and oxidative phosphorylation rates | Metabolic reprogramming assessment |
Enzymatic Activity Assays
Pyruvate carboxylase activity can be measured spectrophotometrically by coupling oxaloacetate production to NADH oxidation via malate dehydrogenase. Hyperpolarized [1-13C]-l-lactate magnetic resonance spectroscopy has been developed as a non-invasive method to assess hepatic PC activity in vivo.
Metabolic Flux Analysis
Stable isotope tracing with 13C-labeled substrates (e.g., [3-13C]pyruvate or [U-13C]glucose) combined with mass spectrometry allows quantification of PC flux into the TCA cycle and gluconeogenic pathways. This method is essential for understanding metabolic reprogramming in cancer and immune cells.
Genetic Knockout and Knockdown
CRISPR-Cas9-mediated knockout or siRNA/shRNA knockdown of PC is widely used to study its loss-of-function phenotypes in cell lines and animal models. These approaches have revealed PC's roles in fibrosis, atherosclerosis, and tumor immunity [2,5,8].
Protein Expression and Localization
Western blotting, immunofluorescence, and subcellular fractionation are used to assess PC protein levels and mitochondrial localization. These methods help confirm successful genetic manipulation and tissue-specific expression.
How CRISPR Can Be Used to Study GO:0004736 pyruvate carboxylase activity
Knockout
CRISPR-Cas9 knockout of PC is used to completely ablate pyruvate carboxylase activity, enabling studies of its essential roles in gluconeogenesis, anaplerosis, and disease progression. For example, PC knockout in renal tubular cells promoted fibrosis via SQOR/cGAS/STING-mediated glycolysis, and macrophage-specific PC knockout aggravated atherosclerosis.
Point Mutation
Point mutations in the PC gene can be introduced to mimic human disease-associated variants or to dissect catalytic residues. For instance, mutations in the biotin carboxylase domain can abolish enzymatic activity, helping to map functional domains. CRISPR prime editing or homology-directed repair can generate such precise mutations.
Knock-in
Knock-in of epitope tags (e.g., FLAG, HA) or fluorescent proteins into the endogenous PC locus allows for real-time tracking of PC expression and localization without overexpression artifacts. This approach is valuable for studying PC dynamics in live cells.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of PC is used to study gain-of-function phenotypes, such as enhanced gluconeogenesis or tumor growth. Overexpression of PC in liver cancer cells can increase oxaloacetate production and support proliferation.
How EDITGENE Supports pyruvate carboxylase activity Research
Researchers studying pyruvate carboxylase activity-related genes often need to determine whether a candidate gene is causally involved in metabolic reprogramming, disease progression, or therapeutic response. Precise genetic models are essential to validate targets and elucidate mechanisms.
Contact EDITGENE today to design your custom CRISPR model for pyruvate carboxylase activity research.
Frequently Asked Questions About pyruvate carboxylase activity
What is pyruvate carboxylase activity?
Pyruvate carboxylase activity (GO:0004736) is the ATP-dependent conversion of pyruvate to oxaloacetate, a key anaplerotic reaction that replenishes TCA cycle intermediates.
What genes are involved in pyruvate carboxylase activity?
The primary gene is PC, which encodes the enzyme. Other related genes include PCK1, PCK2, and metabolic regulators like HIF1A and SQOR [2,3,5].
What is the role of pyruvate carboxylase in cancer?
PC supports tumor growth by providing oxaloacetate for biosynthesis and energy production. Its activation can exhibit anti-liver cancer activity, while its inhibition may alter immune responses [1,8].
How is pyruvate carboxylase activity regulated?
It is allosterically activated by acetyl-CoA and regulated by transcriptional and post-translational mechanisms [4,7].
What diseases are associated with pyruvate carboxylase deficiency?
PC deficiency causes lactic acidosis and neurological impairment. Dysregulation is also linked to renal fibrosis, atherosclerosis, and cancer [2,5,7].
How can I measure pyruvate carboxylase activity?
Enzymatic assays, hyperpolarized 13C MRS, and 13C metabolic flux analysis are commonly used [6,8].
What are the substrates of pyruvate carboxylase?
The substrates are pyruvate, ATP, and bicarbonate. The products are oxaloacetate, ADP, and phosphate.
What is the role of acetyl-CoA in pyruvate carboxylase activity?
Acetyl-CoA is an essential allosteric activator that induces conformational changes and promotes tetramerization, enhancing catalytic efficiency.
Can pyruvate carboxylase be targeted for therapy?
Yes, small-molecule activators like ganoderic acid T show anti-liver cancer activity, and inhibition may reduce atherosclerosis and fibrosis [1,2,5].
What CRISPR models are available for studying pyruvate carboxylase?
Knockout, point mutation, knock-in, and overexpression models can be generated to study PC function in vitro and in vivo [1,2,5].
Conclusion
Pyruvate carboxylase activity (GO:0004736) is a central metabolic reaction with far-reaching implications in health and disease. Its role in anaplerosis, gluconeogenesis, and lipogenesis makes it a critical node in cellular metabolism, while its dysregulation contributes to cancer, fibrosis, atherosclerosis, and immune dysfunction. Advances in CRISPR-based models and metabolic flux technologies continue to unravel the complexities of PC regulation and its therapeutic potential.
References
- 1. Lei B et al.. 2025. Ganoderic acid T, a novel activator of pyruvate carboxylase, exhibits potent anti-liver cancer activity.. Metabolism 170:156321 PMID: 40480453
- 2. Huang H et al.. 2025. Deletion of Pyruvate Carboxylase in Tubular Epithelial Cell Promotes Renal Fibrosis by Regulating SQOR/cGAS/STING-Mediated Glycolysis.. Adv Sci (Weinh) 12(13):e2408753 PMID: 39836535
- 3. Wallace JC et al.. 1998. Pyruvate carboxylase.. Int J Biochem Cell Biol 30(1):1-5 PMID: 9597748
- 4. Adina-Zada A et al.. 2012. Regulation of the structure and activity of pyruvate carboxylase by acetyl CoA.. Arch Biochem Biophys 519(2):118-30 PMID: 22120519
- 5. Zhao LN et al.. 2025. Pyruvate Carboxylase in Macrophages Aggravates Atherosclerosis by Regulating Metabolism Reprogramming to Promote Inflammatory Responses Through the Hypoxia-Inducible Factor-1 Signaling Pathway.. Adv Sci (Weinh) 12(29):e17128 PMID: 40391718
- 6. Chen J et al.. 2021. Assessment of hepatic pyruvate carboxylase activity using hyperpolarized [1-(13) C]-l-lactate.. Magn Reson Med 85(3):1175-1182 PMID: 32936474
- 7. Valle M. 2017. "Pyruvate Carboxylase, Structure and Function".. Subcell Biochem 83:291-322 PMID: 28271481
- 8. Elia I et al.. 2022. Tumor cells dictate anti-tumor immune responses by altering pyruvate utilization and succinate signaling in CD8(+) T cells.. Cell Metab 34(8):1137-1150.e6 PMID: 35820416
